Intelligent Bio Solutions Inc.
INBS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,718 | $9,071 | $8,312 | $6,350 |
| - Cash | $1,660 | $1,020 | $2,807 | $2,242 |
| + Debt | $1,952 | $282 | $511 | $626 |
| Enterprise Value | $9,010 | $8,333 | $6,016 | $4,734 |
| Revenue | $1,112 | $844 | $729 | $607 |
| % Growth | 31.7% | 15.8% | 20% | – |
| Gross Profit | $518 | $336 | $341 | $223 |
| % Margin | 46.6% | 39.8% | 46.8% | 36.7% |
| EBITDA | -$2,676 | -$2,792 | -$2,234 | -$1,936 |
| % Margin | -240.7% | -330.9% | -306.5% | -318.6% |
| Net Income | -$2,983 | -$3,090 | -$2,544 | -$2,249 |
| % Margin | -268.3% | -366.1% | -349% | -370.3% |
| EPS Diluted | -3.5 | -4.4 | -4.4 | -5 |
| % Growth | 20.5% | 0% | 12% | – |
| Operating Cash Flow | -$2,847 | -$2,210 | -$2,755 | -$2,325 |
| Capital Expenditures | -$70 | -$209 | -$14 | -$9 |
| Free Cash Flow | -$2,917 | -$2,418 | -$2,770 | -$2,334 |